What Plan Sponsors Need to Know About HIV Treatment, PrEP and Pharmacy Costs
By Long Tran, Pharm D; Beckie Fenrick, Pharm D; and Jason Peterson, RPh HIV prevention and treatment options are expanding […]
Everyone’s Talking About Pharmacogenomics. The Hard Part Is Making It Work
By Jason Peterson, RPh, Director of Clinical Strategy at Navion For decades, prescribing medication has followed a frustratingly familiar rhythm: try a
GLP-1 Market Update: Oral Drugs, New Formulations, Pipeline Activity, and Pricing Shifts
By Long Tran, Pharm D; Beckie Fenrick, Pharm D; and Jason Peterson, RPh New products are only part of what’s changing in the GLP-1 market. The
International Drug Sourcing Is Under Scrutiny. What Employers Should Understand Before Adopting It
By Jason Peterson, RPh, Director, Clinical Strategy & Monica Gindhart, Vice President Of Business Development For years, international sourcing—where medications are obtained
Direct-to-Consumer (DTC) Prescription Drug Programs
A Simple FAQ for Employers Several drug manufacturers now offer certain medications directly to patients at published cash prices. These
Q1 2026 Drug Updates: New FDA Approvals, Generics, and Biosimilars to Watch
By Beckie Fenrick, PharmD, MBA and Jason Peterson, RPh The first quarter of 2026 brought a steady flow of drug
What Accurate PBM Modeling Really Takes — And Why Clients Deserve More Than a Dashboard
By Greg Sanderson, VP of Analytics Over the last several years, pharmacy analytics has become increasingly visual. Dashboards, charts, and
